Order reprints

Open Access

Glycodelin A is a prognostic marker to predict poor outcome in advanced stage ovarian cancer patients

Christoph Scholz, Sabine Heublein, Miriam Lenhard, Klaus Friese, Doris Mayr and Udo Jeschke*

BMC Research Notes 2012, 5:551  doi:10.1186/1756-0500-5-551

This article is currently available as a provisional PDF. Reprints are produced from the final PDF, which is normally produced within 3 weeks.

Please complete the following form to register your interest in ordering reprints of this article. BioMed Central will contact you by email when the final PDF is available with details of how to obtain a quotation and place an order.

Fields marked * are required

http://www.biomedcentral.com/1756-0500/5/551
1756-0500-5-551